New grad roles at Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company that develops small-molecule therapies designed to modulate RNA processing and control disease-driving gene and protein expression. Its pipeline includes oncology programs such as REM-422, an investigational mRNA degrader targeting MYB.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Series B
- Open roles
- 3
No current roles
Check back soon.
Get new Remix Therapeutics new grad roles by email
Free account. Get new Remix Therapeutics new grad roles by email or push the minute they post.
